NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020-Reference-Cited by-同舟云学术

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

Published:2019-10 Issue:10 Volume:17 Page:1154-1165
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Kumar Shaji K.¹,Callander Natalie S.²,Hillengass Jens³,Liedtke Michaela⁴,Baljevic Muhamed⁵,Campagnaro Erica⁶,Castillo Jorge J.⁷,Chandler Jason C.⁸,Cornell Robert F.⁹,Costello Caitlin¹⁰,Efebera Yvonne¹¹,Faiman Matthew¹²,Garfall Alfred¹³,Godby Kelly¹⁴,Holmberg Leona¹⁵,Htut Myo¹⁶,Huff Carol Ann¹⁷,Kang Yubin¹⁸,Landgren Ola¹⁹,Malek Ehsan¹²,Martin Thomas²⁰,Omel James²¹,Raje Noopur²²,Sborov Douglas²³,Singhal Seema²⁴,Stockerl-Goldstein Keith²⁵,Tan Carlyn²⁶,Weber Donna²⁷,Johnson-Chilla Alyse²⁸,Keller Jennifer²⁸,Kumar Rashmi²⁸

Affiliation:

1. 1Mayo Clinic Cancer Center;

2. 2University of Wisconsin Carbone Cancer Center;

3. 3Roswell Park Comprehensive Cancer Center;

4. 4Stanford Cancer Institute;

5. 5Fred & Pamela Buffett Cancer Center;

6. 6University of Michigan Rogel Cancer Center;

7. 7Dana-Farber/Brigham and Women’s Cancer Center;

8. 8St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

9. 9Vanderbilt-Ingram Cancer Center;

10. 10UC San Diego Moores Cancer Center;

11. 11The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

12. 12Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

13. 13Abramson Cancer Center at the University of Pennsylvania;

14. 14O'Neal Comprehensive Cancer Center at UAB;

15. 15Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

16. 16City of Hope National Medical Center;

17. 17The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

18. 18Duke Cancer Institute;

19. 19Memorial Sloan Kettering Cancer Center;

20. 20UCSF Helen Diller Family Comprehensive Cancer Center;

21. 21Patient Advocate;

22. 22Massachusetts General Hospital Cancer Center;

23. 23Huntsman Cancer Institute at the University of Utah;

24. 24Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

25. 25Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

26. 26Fox Chase Cancer Center;

27. 27The University of Texas MD Anderson Cancer Center; and

28. 28National Comprehensive Cancer Network.

Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orbital Myeloma and Plasmacytoma: An Australian Study;Ophthalmic Plastic & Reconstructive Surgery;2024-09-10

2. Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis;Hematology;2024-09-09

3. Unraveling the interplay between inflammation and stem cell mobilization or homing: Implications for tissue repair and therapeutics;Tzu Chi Medical Journal;2024-09-05

4. Radiomic nomogram for predicting high-risk cytogenetic status in multiple myeloma based on fat-suppressed T2-weighted magnetic resonance imaging;Journal of Bone Oncology;2024-08

5. Oral manifestations of multiple myeloma – A systematic review;Oral Oncology Reports;2024-06